STRO Sutro Biopharma Inc.: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik sutrobio.com (STRO)

Sutro Biopharma, Inc. (STRO) is developing precision ADC drugs through cell-free protein synthesis. The EV/Sales multiple demonstrates market interest in the assets, with the metric currently standing at 5798.94. Growth potential is driven by clinical trials of targeted anti-tumor agents and the recruitment of leading oncobiologists who are creating breakthrough medical solutions in high-tech R&D laboratories.

Nilai perusahaan marang pendapatan: Sutro Biopharma Inc. (STRO) kanggo 23.11.2025 - 20.11.2026

sutrobio.com - rincian analitis lan metrik utama (STRO)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Sutro Biopharma, Inc. STRO
Sampel barang Sutro Biopharma, Inc.

As a non-cyclical immuno-oncology business, Sutro Biopharma, Inc. (STRO) demonstrates high macro-resilience, where asset value is driven by clinical achievements and partnerships. By analyzing the EV-to-revenue ratio, an investor assesses the total enterprise value independent of debt load, which reveals the company's actual market stability and the balance between operational reliability and return potential.

Analisis pesaing Sutro Biopharma, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP